<!DOCTYPE html>
<html lang="en-us">
  <head>
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    
    <title>Posts | Fallingstar Daily R</title>
    <link rel="stylesheet" href="/css/style.css" />
    <link rel="stylesheet" href="/css/fonts.css" />
    <link href="//cdn.bootcss.com/highlight.js/9.12.0/styles/github.min.css" rel="stylesheet">

  </head>

  <body>
    <nav class="header">
      <div class="banner">
<a href="/" class="text">
&Ffr;&Afr;&Lfr;&Lfr;&Ifr;&Nfr;&Gfr;&Sfr;&Tfr;&Afr;&Rfr; &Dfr;&Afr;&Ifr;&Lfr;&Yfr; &Rfr;
</a>
</div>

      <div class="head-meta">
      
        <span>Posts</span>
        <span>2024-05-21</span>
      
      </div>
    </nav>


<div class="container">
<main class="list">

<section class="article-list">
  <h1><a href="https://blogs.rstudio.com/tensorflow/posts/2024-05-21-keras3">Introducing Keras 3 for R</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-21</span>
  </div>
  <div class="summary">
    <a href="/post/blogs-rstudio-com-tensorflow-posts-2024-05-21-keras3/">
    
    
    
    
    
      
    
    We are thrilled to introduce {keras3}, the next version of the Keras R package. {keras3} is a ground-up rebuild of {keras}, maintaining the beloved features of the original while refining and simplifying the API based on valuable insights gathered over the past few &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38769795/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240521183404&amp;v=2.18.0.post9&#43;e462414">Safety and tolerability of radiotherapy in combination with systemic targeted therapies for treatment of hepatocellular carcinoma: a narrative review</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-21</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38769795-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240521183404-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Existing data suggests that combination RT and targeted therapy given the risk of severe adverse events including hepatotoxicity and GI toxicity. There is an urgent need for future studies specifically examining the impact of combination therapy in HCC patients to guide clinical decision-making in the evolving landscape of immune- and targeted &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38769902/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240521183404&amp;v=2.18.0.post9&#43;e462414">Item performance of the scale for the assessment and rating of ataxia in rare and ultra-rare genetic ataxias</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-21</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38769902-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240521183404-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The Scale for the Assessment and Rating of Ataxia (SARA) is widely used for assessing the severity and progression of genetic cerebellar ataxias. SARA is now considered a primary end point in several ataxia treatment trials, but its underlying composite item measurement model has not yet been tested. This work aimed to evaluate the composite properties of SARA and its items using item response theory (IRT) and to demonstrate its applicability across even ultra-rare genetic ataxias. &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38769948/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240521183404&amp;v=2.18.0.post9&#43;e462414">Activity of afatinib in patients with NSCLC harboring novel uncommon &lt;em&gt;EGFR&lt;/em&gt; mutations with or without co-mutations: a case report</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-21</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38769948-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240521183404-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) represent first-line standard of care in unresectable EGFR mutation-positive (EGFRm+) non-small cell lung cancer (NSCLC). However, 10-20% of patients with EGFRm+ NSCLC have uncommon EGFR variants, defined as mutations other than L858R substitutions or exon 19 deletions. NSCLC harboring uncommon EGFR mutations may demonstrate lower sensitivity to targeted agents than NSCLC with L858R or exon 19 deletion &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38770115/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240521183404&amp;v=2.18.0.post9&#43;e462414">Similarity of Seroma Rate at the Medial Thigh following Free Flap Harvesting or Medial Thigh Lift: A Systematic Review and Meta-analysis</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-21</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38770115-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240521183404-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Despite the growing use of autologous breast reconstruction with medial thigh-based free flaps, such as transverse upper gracilis (TMG) or profunda artery perforator (PAP) flaps, these procedures are infrequently performed on patients with obesity. This systematic review and meta-analysis aimed to compare the frequency of seroma occurrence, a common complication after medial thigh flap surgery. Comparison was performed between TMG and PAP flaps, as well as medial thigh lifts (MTL), a &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38770165/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240521183404&amp;v=2.18.0.post9&#43;e462414">Is neoadjuvant chemotherapy followed by surgery the appropriate treatment for esophagogastric signet ring cell carcinomas? A systematic review and meta-analysis</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-21</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38770165-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240521183404-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: The current meta-analysis could not demonstrate beneficial effects of nCTX for SRCC patients. Histopathological response to and survival benefits of non-taxane-based nCTX seem to be lower in comparison to non-SRC esophagogastric cancer. However, certainty of evidence is low due to the scarcity of high-quality trials. Further research is necessary to determine optimal treatment for SRCC &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38770539/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240521183404&amp;v=2.18.0.post9&#43;e462414">A photoaging smartphone application to promote sun safety behaviors among youth in late childhood and adolescence</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-21</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38770539-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240521183404-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: The findings of this cross-sectional study suggest that a photoaging smartphone application may serve as a useful tool to promote sun safety behaviors from a young &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38770848/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240521183404&amp;v=2.18.0.post9&#43;e462414">Toward a causal model of curiosity and creativity</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-21</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38770848-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240521183404-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    We extend Ivancovsky et al.&rsquo;s finding on the association between curiosity and creativity by proposing a sequential causal model assuming that (a) curiosity determines the motivation to seek information and that (b) creativity constitutes a capacity to act on that motivation. This framework assumes that both high levels of curiosity and creativity are necessary for information-seeking &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38770889/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240521183000&amp;v=2.18.0.post9&#43;e462414">Audio Interview: The Current State of Avian Influenza</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-21</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38770889-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240521183000-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38770914/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240521183404&amp;v=2.18.0.post9&#43;e462414">Closing the loop between environment, brain and mental health: how far we might go in real-life assessments?</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-21</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38770914-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240521183404-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    PURPOSE OF REVIEW: Environmental factors such as climate, urbanicity, and exposure to nature are becoming increasingly important influencers of mental health. Incorporating data gathered from real-life contexts holds promise to substantially enhance laboratory experiments by providing a more comprehensive understanding of everyday behaviors in natural environments. We provide an up-to-date review of current technological and methodological developments in mental health assessments, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38771375/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240521183404&amp;v=2.18.0.post9&#43;e462414">Heritable pulmonary arterial hypertension</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-21</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38771375-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240521183404-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Heritable pulmonary arterial hypertension (PAH) can be triggered by at least 18 genes. The most frequently altered gene is the bone morphogenetic protein receptor 2 (BMPR2). Further genes from the same pathway are also well known PAH-causing genes. Genetic testing can aid to confirm differential diagnoses such as a pulmonary veno-occlusive disease. It also enables the testing of healthy family members. In addition to the PAH patient population particularly served by genetic testing, this &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38771544/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240521183404&amp;v=2.18.0.post9&#43;e462414">Diagnostic accuracy of Afirma Gene Expression Classifier, Afirma Gene Sequencing Classifier, ThyroSeq v2 and ThyroSeq v3 for indeterminate (Bethesda III and IV) thyroid nodules: a meta-analysis</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-21</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38771544-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240521183404-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: We showed that in patients with ITN, TSv3 has the best molecular diagnostic performance, followed by TSv2, GSC, and GEC. For rule-out malignancy, GSC, and for rule-in, TSV2 is superior to other &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pypi.org/project/label-studio/1.12.1/">1.12.1</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-21</span>
  </div>
  <div class="summary">
    <a href="/post/pypi-org-project-label-studio-1-12-1/">
    
    
    
    
    
      
    
    Label Studio annotation &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OfmBrybyb">🔻内塔尼亚胡：“指控我在加沙的罪行就像指控乔治·布什犯有9/11事件的罪行一样。”🔻……🔻🇺🇸：[哆啦A梦害怕] 🔻太敢讲了，你还真是什么话都敢讲...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-21</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ofmbrybyb/">
    
    
    
    
    
      
    
    🔻内塔尼亚胡：“指控我在加沙的罪行就像指控乔治·布什犯有9/11事件的罪行一样。”<!-- raw HTML omitted -->🔻……<!-- raw HTML omitted -->🔻🇺🇸：<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted -->🔻太敢讲了，你还真是什么话都敢讲啊。<!-- raw HTML omitted -->🔻via ABC news<!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B8%AD%E6%96%B9%E8%A6%81%E6%B1%82%E4%BB%A5%E8%89%B2%E5%88%97%E7%AB%8B%E5%8D%B3%E5%81%9C%E6%AD%A2%E5%86%9B%E4%BA%8B%E8%BF%9B%E6%94%BB%E6%8B%89%E6%B3%95%23&amp;amp;extparam=%23%E4%B8%AD%E6%96%B9%E8%A6%81%25">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B8%AD%E6%96%B9%E8%A6%81%E6%B1%82%E4%BB%A5%E8%89%B2%E5%88%97%E7%AB%8B%E5%8D%B3%E5%81%9C%E6%AD%A2%E5%86%9B%E4%BA%8B%E8%BF%9B%E6%94%BB%E6%8B%89%E6%B3%95%23&amp;amp;extparam=%23%E4%B8%AD%E6%96%B9%E8%A6%81%</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OfmG0lt3E">🔻还记得沙尼卢克吗？（图1）🔻沙尼卢克的父亲尼西姆-卢克（Nissim Louk）上周五对《纽约邮报》说：“我们现在拥有的这具遗体是完整而美丽的，看起来她还活...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-21</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ofmg0lt3e/">
    
    
    
    
    
      
    
    🔻还记得沙尼卢克吗？（图1）<!-- raw HTML omitted -->🔻沙尼卢克的父亲尼西姆-卢克（Nissim Louk）上周五对《纽约邮报》说：“我们现在拥有的这具遗体是完整而美丽的，看起来她还活着。我认为她曾在一个非常非常寒冷的隧道里&hellip;&hellip;这就是为什么尸体完整而美丽，皮肤的颜色依然如故，你依然能看到纹身，这太神奇了。”（视频2，图3）<!-- raw HTML omitted -->🔻这是沙尼卢克的父母与什穆利-博塔赫对话的一部分。<!-- raw HTML omitted -->🔻……总感觉有哪里不对，让我们来捋一捋：<!-- raw HTML omitted -->🔻首先，自去年 10 月 7 日以来，她一直出现在以色列的宣传中，以色列的总统在去年 10 月 30 日至 31 日说“她的尸 体被发现被斩 首”（图4-5，以色列i24新闻频道）。<!-- raw HTML omitted -->🔻当时，他们声称他们发现了她的头骨，所以他们认为她已经死了，他们使用“斩 首”的宣传。<!-- raw HTML omitted -->🔻然而，她的遗体号称最近在拉法被发现并送回来了，你猜怎么着？她的遗体完好无损，“看起来她还活着”，正如她父母所承认的那样。<!-- raw HTML omitted -->🔻那去年以色列总统声称发现的是什么？总统哎……<!-- raw HTML omitted -->🔻……有没有熟悉法医工作的网友，感觉真的对不上。&lt;img style=&quot;&quot; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Ofmglzyut">🔻多管火箭炮袭击别洛戈罗夫卡。🔻via VK 包容万物恒河水的微博视频</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-21</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ofmglzyut/">
    
    
    
    
    
      
    
    🔻多管火箭炮袭击别洛戈罗夫卡。<!-- raw HTML omitted -->🔻via VK <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->包容万物恒河水的微博视频<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;source src=&ldquo;<a href="https://f.video.weibocdn.com/o0/EJE2NGdJlx08f2hELbeE010412">https://f.video.weibocdn.com/o0/EJE2NGdJlx08f2hELbeE010412</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OfmlVcCYR">🔻美联社的一篇报道。🔻图8是2013 年 8 月 25 日，在加利福尼亚州优胜美地国家公园附近的大火期间，囚犯消防员沿着 120 号高速公路行走。🔻图9中，一些全...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-21</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ofmlvccyr/">
    
    
    
    
    
      
    
    🔻美联社的一篇报道。<!-- raw HTML omitted -->🔻图8是2013 年 8 月 25 日，在加利福尼亚州优胜美地国家公园附近的大火期间，囚犯消防员沿着 120 号高速公路行走。<!-- raw HTML omitted -->🔻图9中，一些全女性囚犯队伍被派去清理内华达州的野火热点，她们只接受过课堂培训，她们在闷烧的余烬上跳了一段“热脚舞”，因为她们的老板大喊“回到那里”，一名女性囚犯工人被烧毁的靴子被用胶带粘在一起，而其他人则痛苦地哭泣，因为她们的袜子在地上融化了九个小时，每小时报酬约1美元。<!-- raw HTML omitted -->🔻两天后，这些妇女最终被送往外面的一家医院，医生从她们的脚底切下死皮，这些脚被二度烧伤。因为她们是囚犯，所以她们被剥夺了止痛药。<!-- raw HTML omitted -->🔻根据美国宪法第 13 条修正案，美国有实际的奴隶劳动，该修正案规定“奴隶制和非自愿奴役作为对犯罪的惩罚是合法的”，超过80万囚犯为“每小时几美分或根本没有”工作。<!-- raw HTML omitted -->🔻美国也是迄今为止世界上监禁率最高的国家。<!-- raw HTML omitted -->🔻美国是世界上仅有的两个没有批准1930年《强迫劳动公约》的国家之一，另一个没有批准它的国家是阿富汗。总而言之，美国只批准了17项国际劳工组织（ILO）公约（图13），这基本上是世界上最低的， &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OfmnnCMmy">🔻草。🔻三哥多奇志。🔻via Abhiram K. J. 包容万物恒河水的微博视频</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-21</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ofmnncmmy/">
    
    
    
    
    
      
    
    🔻草。<!-- raw HTML omitted -->🔻三哥多奇志。<!-- raw HTML omitted -->🔻via Abhiram K. J. <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->包容万物恒河水的微博视频<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;source src=&ldquo;<a href="https://f.video.weibocdn.com/o0/ovdq2I8Tlx08f2iQvG">https://f.video.weibocdn.com/o0/ovdq2I8Tlx08f2iQvG</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OfmoKrdSg">🔻美联社：美联社记者一直在以色列南部拍摄加沙全景，但是周二，以色列官员突袭了这里，没收了扣押了属于美联社的相机和广播设备，并撤下了实况直播。🔻这次...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-21</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ofmokrdsg/">
    
    
    
    
    
      
    
    🔻美联社：美联社记者一直在以色列南部拍摄加沙全景，但是周二，以色列官员突袭了这里，没收了扣押了属于美联社的相机和广播设备，并撤下了实况直播。<!-- raw HTML omitted -->🔻这次突袭是在周四口头命令停止直播之后进行的，美联社拒绝这样做。<!-- raw HTML omitted -->🔻以色列反对党领袖亚伊尔-拉皮德称此举为“疯狂之举”。<!-- raw HTML omitted -->🔻“这不是半岛电视台。这是一家美国新闻机构，”他说。“这个政府的行为就好像它决定不惜一切代价确保以色列在全世界遭到唾弃。”<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax2.sinaimg.cn/large/639b1bfbly1hpxjql85egj20or0kwjwr.jpg%22">https://tvax2.sinaimg.cn/large/639b1bfbly1hpxjql85egj20or0kwjwr.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OfmoZr0uj">说是某地“音乐节”//@路遥知马力Emmm:这啥啊 - 转发 @包容万物恒河水:&amp;ensp;🔻草。🔻三哥多奇志。🔻via Abhiram K. J. 包容万物恒河水的微博视频</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-21</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ofmozr0uj/">
    
    
    
    
    
      
    
    说是某地“音乐节”//<!-- raw HTML omitted -->@路遥知马力Emmm<!-- raw HTML omitted -->:这啥啊<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@包容万物恒河水<!-- raw HTML omitted -->: 🔻草。<!-- raw HTML omitted -->🔻三哥多奇志。<!-- raw HTML omitted -->🔻via Abhiram K. J. <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->包容万物恒河水的微博视频<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted -->&lt;br &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OfmvBzwdU">🔻草 包容万物恒河水的微博视频</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-21</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ofmvbzwdu/">
    
    
    
    
    
      
    
    🔻草 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->包容万物恒河水的微博视频<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;source src=&ldquo;<a href="https://f.video.weibocdn.com/o0/ZFLKaoC4lx08f2keMIdG01041200aNGu0E010.mp4?label=mp4_720p">https://f.video.weibocdn.com/o0/ZFLKaoC4lx08f2keMIdG01041200aNGu0E010.mp4?label=mp4_720p</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Ofn5cCp6Y">🔻这是伊朗总统办公室主任吴拉姆·莫辛·埃斯迈利对伊朗总统直升机坠机事件描述的重要和新细节，他当时在第三架直升机上。🔻采访由 IRIBNEWS 播出（伊朗广播...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-21</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ofn5ccp6y/">
    
    
    
    
    
      
    
    🔻这是伊朗总统办公室主任吴拉姆·莫辛·埃斯迈利对伊朗总统直升机坠机事件描述的重要和新细节，他当时在第三架直升机上。<!-- raw HTML omitted -->🔻采访由 IRIBNEWS 播出（伊朗广播电视台，是伊朗第一家广播电台，成立于1938年，是伊朗唯一覆盖全国的广播电视媒体）。<!-- raw HTML omitted -->🔻吴拉姆·莫辛·埃斯迈利说：<!-- raw HTML omitted -->🔹我们在当地举行了一个多小时的新外交会议，中午进行了祈祷，当地民众也有要求。阿亚图拉莱西出现在该地区的祈祷大厅并回答了人们的请求。<!-- raw HTML omitted -->🔹经过中午的祈祷和会众，下午一点左右，飞往大不里士的航班在天气晴朗、没有任何特殊天气现象的情况下起飞。<!-- raw HTML omitted -->🔹在 Songun 铜矿区附近的山谷中移动45分钟后，我看到一片云块像天空中的桌子一样蔓延，地面上有雾，但我们乘坐直升机前进的空中没有雾。不过，在一个小的密集区域，悬崖上方有一小片云。从高度上看，这片云与我们的飞行高度相同，甚至我们比云还要低一点。<!-- raw HTML omitted -->🔹在那里，担任总统直升机 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Ofn6gor6p">你要说911有阴谋，那我可就真信了嗷？ - 转发 @包容万物恒河水:&amp;ensp;🔻内塔尼亚胡：“指控我在加沙的罪行就像指控乔治·布什犯有9/11事件的罪行一样。”🔻...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-21</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ofn6gor6p/">
    
    
    
    
    
      
    
    你要说911有阴谋，那我可就真信了嗷？<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@包容万物恒河水<!-- raw HTML omitted -->: 🔻内塔尼亚胡：“指控我在加沙的罪行就像指控乔治·布什犯有9/11事件的罪行一样。”<!-- raw HTML omitted -->🔻……<!-- raw HTML omitted -->🔻🇺🇸：<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted -->🔻太敢讲了，你还真是什么话都敢讲啊。<!-- raw HTML omitted -->🔻via ABC news<!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B8%AD%E6%96%B9%E8%A6%81%E6%B1%82%E4%BB%A5%E8%89%B2%E5%88%97%E7%AB%8B%E5%8D%B3%E5%258">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B8%AD%E6%96%B9%E8%A6%81%E6%B1%82%E4%BB%A5%E8%89%B2%E5%88%97%E7%AB%8B%E5%8D%B3%E5%8</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OfloLwwv4">久保史绪里Via.乃木坂46 X [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-21</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-oflolwwv4/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->Via.乃木坂46 X <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38764777/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240520180926&amp;v=2.18.0.post9&#43;e462414">Targeting thalamocortical circuits for closed-loop stimulation in Lennox-Gastaut syndrome</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38764777-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240520180926-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    This paper outlines the therapeutic rationale and neurosurgical targeting technique for bilateral, closed-loop, thalamocortical stimulation in Lennox-Gastaut syndrome, a severe form of childhood-onset epilepsy. Thalamic stimulation can be an effective treatment for Lennox-Gastaut syndrome, but complete seizure control is rarely achieved. Outcomes may be improved by stimulating areas beyond the thalamus, including cortex, but the optimal targets are unknown. We aimed to identify a cortical &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38765202/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240520180926&amp;v=2.18.0.post9&#43;e462414">Dummy run for planning of isotoxic dose-escalated radiation therapy for glioblastoma used in the PRIDE trial (NOA-28; ARO-2024-01; AG-NRO-06)</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38765202-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240520180926-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: The deviations revealed the necessity of systematic trainings with appropriate feedback before the start of clinical trials in radiation oncology and the constant monitoring of protocol compliance throw-out the &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38765263/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240520180926&amp;v=2.18.0.post9&#43;e462414">Evolution of peripheral nerve changes in early multiple sclerosis-a longitudinal MR neurography study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38765263-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240520180926-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Peripheral nerve involvement in MS appears at initial diagnosis and continues to evolve within 1 year follow-up with individual dynamics. Quantitative MRN provides non-invasive biomarkers to detect and monitor peripheral nerve changes in &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38765578/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240520180926&amp;v=2.18.0.post9&#43;e462414">Steroid-Resistant Nephrotic Syndrome due to &lt;em&gt;NPHS2&lt;/em&gt; Variants Is Not Associated With Posttransplant Recurrence</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38765578-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240520180926-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: In this large cohort, the risk of patients with causative variants in the NPHS2 gene to develop NS recurrence after kidney transplantation was extremely low. This is coherent with the pathophysiology of intrinsic slit-diaphragm disease. These data are reassuring and should be considered when counselling patients, making living kidney donation, whether related or not, a safe &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38765898/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240520180926&amp;v=2.18.0.post9&#43;e462414">Management of Patients with Breast Biopsy under Anti-Coagulation or Anti-Platelet Therapy: Results of a Survey of German Experts</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38765898-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240520180926-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Breast biopsies for patients on ASA or prophylactic heparin are deemed safe and part of standard clinical practice. However, despite available feasibility studies, conducting breast biopsies on ACT medications such as DOACs or phenprocoumon appears feasible only for a minority of &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38767063/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240520180926&amp;v=2.18.0.post9&#43;e462414">Hypoparathyroidism update</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38767063-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240520180926-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    PURPOSE OF REVIEW: Since the release of the 2022 Second International Workshop Evaluation and Management of Hypoparathyroidism Summary Statement and Guidelines, updates and advances are now available in the cause, complications, and treatment of adult chronic hypoparathyroidism (hypoPTH). This review aims to highlight these new findings and implications to patient &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38767091/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240520180926&amp;v=2.18.0.post9&#43;e462414">Successful Aging and Subjective Aging: Toward a Framework to Research a Neglected Connection</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38767091-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240520180926-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Research related to subjective aging, which describes how individuals perceive, interpret and evaluate their own aging, has substantially grown in the past two decades. Evidence from longitudinal studies shows that subjective aging predicts health, quality of life, and functioning in later life. However, the existing literature on successful aging has mostly neglected the role of subjective aging. This paper proposes an extended framework of successful aging linking subjective aging &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38767162/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240520180926&amp;v=2.18.0.post9&#43;e462414">Association between self-reported functional capacity measures and postoperative myocardial injury in patients undergoing noncardiac surgeries</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38767162-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240520180926-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38767162/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240521183404&amp;v=2.18.0.post9&#43;e462414">Association between self-reported functional capacity measures and postoperative myocardial injury in patients undergoing noncardiac surgeries</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38767162-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240521183404-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38767179/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240520180926&amp;v=2.18.0.post9&#43;e462414">Skin fragility and wound management in Ehlers- Danlos Syndrome: a report by the Ehlers Danlos Syndrome society skin working group</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38767179-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240520180926-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The Ehlers-Danlos Syndromes (EDS) are a heterogenous group of heritable connective tissue disorders, characterised by joint hypermobility, skin hyperextensibility and generalised tissue fragility. In all types of EDS skin wound healing is impaired to a variable degree. Additional support through wound management plans may help to improve these outcomes, however, there is paucity of evidence regarding clinical management of skin fragility and wounds in EDS. This paper aims to review &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38767179/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240521183404&amp;v=2.18.0.post9&#43;e462414">Skin fragility and wound management in Ehlers- Danlos Syndrome: a report by the Ehlers Danlos Syndrome society skin working group</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38767179-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240521183404-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The Ehlers-Danlos Syndromes (EDS) are a heterogenous group of heritable connective tissue disorders, characterised by joint hypermobility, skin hyperextensibility and generalised tissue fragility. In all types of EDS skin wound healing is impaired to a variable degree. Additional support through wound management plans may help to improve these outcomes, however, there is paucity of evidence regarding clinical management of skin fragility and wounds in EDS. This paper aims to review &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38767226/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240520180926&amp;v=2.18.0.post9&#43;e462414">Procedural and clinical outcomes of patients undergoing a TAVI in TAVI procedure: Rationale and design of the multicentre, prospective, observational ReTAVI registry</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38767226-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240520180926-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: The registry will collect pre-, peri-, postoperative and 12-months data on patients undergoing repeated TAVI procedures with THVs for failure of the index THV and determine VARC-3-defined efficacy and safety at 30 days and functional outcome at 12 months. The registry will expand existing data sets and identify patient characteristics/indicators related to complications and clinical benefits for patients with symptomatic severe calcific degenerative aortic &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38767226/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240521183404&amp;v=2.18.0.post9&#43;e462414">Procedural and clinical outcomes of patients undergoing a TAVI in TAVI procedure: Rationale and design of the multicentre, prospective, observational ReTAVI registry</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38767226-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240521183404-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: The registry will collect pre-, peri-, postoperative and 12-months data on patients undergoing repeated TAVI procedures with THVs for failure of the index THV and determine VARC-3-defined efficacy and safety at 30 days and functional outcome at 12 months. The registry will expand existing data sets and identify patient characteristics/indicators related to complications and clinical benefits for patients with symptomatic severe calcific degenerative aortic &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38767237/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240520180847&amp;v=2.18.0.post9&#43;e462414">Beyond Diagnostics - Removing Race from Lung-Function Test Interpretation</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38767237-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240520180847-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38767237/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240521183000&amp;v=2.18.0.post9&#43;e462414">Beyond Diagnostics - Removing Race from Lung-Function Test Interpretation</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38767237-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240521183000-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38767244/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240520180847&amp;v=2.18.0.post9&#43;e462414">A Modular Communicative Leadless Pacing-Defibrillator System</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38767244-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240520180847-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: The leadless pacemaker in wireless communication with a subcutaneous ICD exceeded performance goals for freedom from major complications related to the leadless pacemaker, for communication between the leadless pacemaker and subcutaneous ICD, and for the percentage of patients with a pacing threshold up to 2.0 V at a 0.4-msec pulse width at 6 months. (Funded by Boston Scientific; MODULAR ATP ClinicalTrials.gov &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38767244/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240521183000&amp;v=2.18.0.post9&#43;e462414">A Modular Communicative Leadless Pacing-Defibrillator System</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38767244-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240521183000-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: The leadless pacemaker in wireless communication with a subcutaneous ICD exceeded performance goals for freedom from major complications related to the leadless pacemaker, for communication between the leadless pacemaker and subcutaneous ICD, and for the percentage of patients with a pacing threshold up to 2.0 V at a 0.4-msec pulse width at 6 months. (Funded by Boston Scientific; MODULAR ATP ClinicalTrials.gov &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38767248/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240520180847&amp;v=2.18.0.post9&#43;e462414">Early Diagnosis and Treatment of COPD and Asthma - A Randomized, Controlled Trial</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38767248-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240520180847-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: In this trial in which a strategy was used to identify adults in the community with undiagnosed asthma or COPD, those who received pulmonologist-directed treatment had less subsequent health care utilization for respiratory illness than those who received usual care. (Funded by Canadian Institutes of Health Research; UCAP ClinicalTrials.gov number, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38767248/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240521183000&amp;v=2.18.0.post9&#43;e462414">Early Diagnosis and Treatment of COPD and Asthma - A Randomized, Controlled Trial</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38767248-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240521183000-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: In this trial in which a strategy was used to identify adults in the community with undiagnosed asthma or COPD, those who received pulmonologist-directed treatment had less subsequent health care utilization for respiratory illness than those who received usual care. (Funded by Canadian Institutes of Health Research; UCAP ClinicalTrials.gov number, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38767252/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240520180847&amp;v=2.18.0.post9&#43;e462414">Implications of Race Adjustment in Lung-Function Equations</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38767252-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240520180847-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: The use of race-based and race-neutral equations generated similarly accurate predictions of respiratory outcomes but assigned different disease classifications, occupational eligibility, and disability compensation for millions of persons, with effects diverging according to race. (Funded by the National Heart Lung and Blood Institute and the National Institute of Environmental Health &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38767252/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240521183000&amp;v=2.18.0.post9&#43;e462414">Implications of Race Adjustment in Lung-Function Equations</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38767252-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240521183000-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: The use of race-based and race-neutral equations generated similarly accurate predictions of respiratory outcomes but assigned different disease classifications, occupational eligibility, and disability compensation for millions of persons, with effects diverging according to race. (Funded by the National Heart Lung and Blood Institute and the National Institute of Environmental Health &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38767511/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240520180849&amp;v=2.18.0.post9&#43;e462414">Increased risk of venous thromboembolism in young and middle-aged individuals with hereditary angioedema: a family study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38767511-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240520180849-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    Hereditary angioedema (HAE) due to C1 inhibitor protein (C1-INH) deficiency was recently shown to be associated with increased risk of venous thromboembolism (VTE). This is the first national family study of HAE with the aim to determine the familial risk of VTE. The Swedish Multi-Generation Register was linked to the Swedish National Patient Register during the period 1964-2018. Only HAE patients with a validated diagnosis were included in the study and were linked to their family &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38767511/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240521183001&amp;v=2.18.0.post9&#43;e462414">Increased risk of venous thromboembolism in young and middle-aged individuals with hereditary angioedema: a family study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38767511-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240521183001-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    Hereditary angioedema (HAE) due to C1 inhibitor protein (C1-INH) deficiency was recently shown to be associated with increased risk of venous thromboembolism (VTE). This is the first national family study of HAE with the aim to determine the familial risk of VTE. The Swedish Multi-Generation Register was linked to the Swedish National Patient Register during the period 1964-2018. Only HAE patients with a validated diagnosis were included in the study and were linked to their family &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38767614/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240520180847&amp;v=2.18.0.post9&#43;e462414">Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38767614-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240520180847-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: In patients with COPD and type 2 inflammation as indicated by elevated blood eosinophil counts, dupilumab was associated with fewer exacerbations and better lung function than placebo. (Funded by Sanofi and Regeneron Pharmaceuticals; NOTUS ClinicalTrials.gov number, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38767614/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240521183000&amp;v=2.18.0.post9&#43;e462414">Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38767614-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240521183000-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: In patients with COPD and type 2 inflammation as indicated by elevated blood eosinophil counts, dupilumab was associated with fewer exacerbations and better lung function than placebo. (Funded by Sanofi and Regeneron Pharmaceuticals; NOTUS ClinicalTrials.gov number, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38767697/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240520180926&amp;v=2.18.0.post9&#43;e462414">Long-term outcome of patients with Ménière&#39;s disease following cochlear implantation: a comprehensive outcome study with validated assessment tools</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38767697-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240520180926-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: CI has positive effects on all areas examined in our cohort. However, discrimination of speech at low sound pressure levels remained problematic postoperatively. In patients suffering from MD, the prioritized treatment goals include not only improved hearing but also the rehabilitation of vertigo and tinnitus, as well as the enhancement of QoL. Validated instruments are useful screening &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38767697/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240521183404&amp;v=2.18.0.post9&#43;e462414">Long-term outcome of patients with Ménière&#39;s disease following cochlear implantation: a comprehensive outcome study with validated assessment tools</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38767697-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240521183404-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: CI has positive effects on all areas examined in our cohort. However, discrimination of speech at low sound pressure levels remained problematic postoperatively. In patients suffering from MD, the prioritized treatment goals include not only improved hearing but also the rehabilitation of vertigo and tinnitus, as well as the enhancement of QoL. Validated instruments are useful screening &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38768337/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240521183001&amp;v=2.18.0.post9&#43;e462414">EVIDENCE meta-analysis: evaluating minimal residual disease as an intermediate clinical endpoint for multiple myeloma</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38768337-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240521183001-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    Estimating progression-free survival (PFS) and overall survival (OS) superiority during clinical trials of multiple myeloma (MM) has become increasingly challenging as novel therapeutics have improved patient outcomes. Thus, it is imperative to identify earlier endpoint surrogates that are predictive of long-term clinical benefit to expedite development of more effective therapies. Minimal residual disease (MRD)-negativity is a common intermediate endpoint that has shown prognostic value &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38768337/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240521183404&amp;v=2.18.0.post9&#43;e462414">EVIDENCE meta-analysis: evaluating minimal residual disease as an intermediate clinical endpoint for multiple myeloma</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38768337-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240521183404-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Estimating progression-free survival (PFS) and overall survival (OS) superiority during clinical trials of multiple myeloma (MM) has become increasingly challenging as novel therapeutics have improved patient outcomes. Thus, it is imperative to identify earlier endpoint surrogates that are predictive of long-term clinical benefit to expedite development of more effective therapies. Minimal residual disease (MRD)-negativity is a common intermediate endpoint that has shown prognostic value &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38768421/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240521183404&amp;v=2.18.0.post9&#43;e462414">Breaking the Mold: Trailblazing Melanoma Therapy Beyond Checkpoint Through Innovative Approaches</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38768421-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240521183404-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Melanoma has long been a difficult malignancy to treat with low response rates to standard chemotherapies. In recent years, the use of immune checkpoint inhibitors have demonstrated promising results, paving the way for the use of the rapidly developing novel immune targeting therapies. In this review, we look beyond immune checkpoint inhibitor treatments and summarize several emerging treatment strategies for melanoma, including neoantigen vaccines, conventional antibody drug-conjugates, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38768763/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240521183404&amp;v=2.18.0.post9&#43;e462414">Cardiomyocyte-specific RXFP1 overexpression protects against pressure overload-induced cardiac dysfunction independently of Relaxin</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38768763-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240521183404-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Heart failure (HF) prevalence is rising due to reduced early mortality and demographic change. Relaxin (RLN) mediates protective effects in the cardiovascular system through Relaxin-receptor 1 (RXFP1). Cardiac overexpression of RXFP1 with additional RLN supplementation attenuated HF in the pressure-overload transverse aortic constriction (TAC) model. Here, we hypothesized that robust transgenic RXFP1 overexpression in cardiomyocytes (CM) protects from TAC-induced HF even in the absence of &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38769164/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240521183404&amp;v=2.18.0.post9&#43;e462414">Validation of the standardization framework SSTR-RADS 1.0 for neuroendocrine tumors using the novel SSTR‑targeting peptide [&lt;sup&gt;18&lt;/sup&gt;F]SiTATE</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38769164-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240521183404-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: SSTR-RADS 1.0 represents a highly reproducible and consistent framework system for stratifying SSTR-targeted PET/CT scans, even using the novel SSTR-ligand [^(18)F]SiTATE. Some inter-reader variability was observed regarding the evaluation of uptake intensity prior to PRRT as well as compartment scoring of lymph nodes, indicating that those categories require special attention during further clinical validation and might be refined in a future SSTR-RADS version &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38769332/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240521183404&amp;v=2.18.0.post9&#43;e462414">Cytomegalovirus drives Vδ1&lt;sup&gt;&#43;&lt;/sup&gt; γδ T cell expansion and clonality in common variable immunodeficiency</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38769332-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240521183404-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The function and phenotype of γδ T cells in the context of common variable immunodeficiency (CVID) has not been explored. CVID is a primary immunodeficiency disorder characterized by impaired antibody responses resulting in increased susceptibility to infections. γδ T cells are a subset of unconventional T cells that play crucial roles in host defence against infections. In this study, we aim to determine the roles and functions of γδ T cells in CVID. We observe a higher frequency of Vδ1^(+) &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38769371/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240521183404&amp;v=2.18.0.post9&#43;e462414">A large and diverse brain organoid dataset of 1,400 cross-laboratory images of 64 trackable brain organoids</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38769371-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240521183404-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Brain organoids represent a useful tool for modeling of neurodevelopmental disorders and can recapitulate brain volume alterations such as microcephaly. To monitor organoid growth, brightfield microscopy images are frequently used and evaluated manually which is time-consuming and prone to observer-bias. Recent software applications for organoid evaluation address this issue using classical or AI-based methods. These pipelines have distinct strengths and weaknesses that are not evident &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/Of7ckoBnH">又是天气大好的一天，而湾区夏天海边没有雾的周末很少见。到San Gregorio走了2 miles。因为天气好，这片平时人迹罕至的海滩今天也有一些游人。 美国·Pescadero ...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-of7ckobnh/">
    
    
    
    
    
      
    
    又是天气大好的一天，而湾区夏天海边没有雾的周末很少见。到San Gregorio走了2 miles。因为天气好，这片平时人迹罕至的海滩今天也有一些游人。 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->美国·Pescadero Beach<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax3.sinaimg.cn/large/4">https://tvax3.sinaimg.cn/large/4</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/Of80AmqGB">San Gregorio海滩。 子陵在听歌的微博视频</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-of80amqgb/">
    
    
    
    
    
      
    
    San Gregorio海滩。 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->子陵在听歌的微博视频<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;source src=&ldquo;<a href="https://f.video.weibocdn.com/o0/kQjosMfvlx08eZQR6pEk01041200hajv0E010.mp4?lab">https://f.video.weibocdn.com/o0/kQjosMfvlx08eZQR6pEk01041200hajv0E010.mp4?lab</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/Of8BAiYep">一个朋友半开玩笑地送我了一本书，没想到读起来觉得还挺有收获的，叫stop walking on eggshells。其实我觉得它很适合很多一代东亚移民家长读给孩子，也算是加深...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-of8baiyep/">
    
    
    
    
    
      
    
    一个朋友半开玩笑地送我了一本书，没想到读起来觉得还挺有收获的，叫stop walking on eggshells。其实我觉得它很适合很多一代东亚移民家长读给孩子，也算是加深自我认知的过程。这本书讲了在生活中我们总会遇到非常难以相处的人，其中不少人有BPD（边缘性人格障碍），非常易激易怒。如果这些人恰是家人或者亲密朋友或者上司，那么处理这种人际关系则变得很具有挑战性。<!-- raw HTML omitted --><!-- raw HTML omitted -->这本书提供的方法第一是set healthy boundaries（有底线），第二是友善而清晰地交流。比如体现在遇到挑衅或争吵（fight）时候不发怒，不立即反应以使对方更激怒，但等对方平静下来后要向对方表示这样做是不对的，然后清晰地告诉对方哪里做得不对让自己底线被碰触。其实这也是一些受过教育的美国家长教育孩子的方式，就是“call out bad behaviour &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1655755343/OfcbyxF0z">一塌糊涂的一天。打烊了看到一样一塌糊涂却还能自已发电的人，很羡慕😆像玛格丽特砸过的废墟里长出了雌雄曼陀罗花，用来让蜜蜂镇痛，让蝴蝶发神经病🦋 [图片...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1655755343-ofcbyxf0z/">
    
    
    
    
    
      
    
    一塌糊涂的一天。打烊了看到一样一塌糊涂却还能自已发电的人，很羡慕😆像玛格丽特砸过的废墟里长出了雌雄曼陀罗花，用来让蜜蜂镇痛，让蝴蝶发神经病🦋 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Ofd3dq0kQ">🔻以色列新消息报：以色列特拉维夫-雅法市环卫部门的13名公务员，因涉嫌 公 共 腐 败与 洗 钱而被捕，初步调查显示他们与雅法的一个大型犯罪组织和家族有关，...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ofd3dq0kq/">
    
    
    
    
    
      
    
    🔻以色列新消息报：以色列特拉维夫-雅法市环卫部门的13名公务员，因涉嫌 公 共 腐 败与 洗 钱而被捕，初步调查显示他们与雅法的一个大型犯罪组织和家族有关，金额高达数亿新谢克尔。<!-- raw HTML omitted -->🔻“国民苦不堪言，你们家人也一样吧？在前线的士兵……” <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Ofd3Svtjp">[鼓掌] - 转发 @风清颂:&amp;ensp;警方的反诈骗讲座，很有道理啊 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ofd3svtjp/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@风清颂<!-- raw HTML omitted -->: 警方的反诈骗讲座，很有道理啊 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Ofd81hqrm">🔻将国际刑事法院对普京和内塔尼亚胡的逮捕令申请进行比较很有意思。🔻普京被国际刑事法院指控为“非法驱逐人口（儿童）和非法将人口（儿童）从乌克兰占领地...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ofd81hqrm/">
    
    
    
    
    
      
    
    🔻将国际刑事法院对普京和内塔尼亚胡的逮捕令申请进行比较很有意思。<!-- raw HTML omitted -->🔻普京被国际刑事法院指控为“非法驱逐人口（儿童）和非法将人口（儿童）从乌克兰占领地区转移到俄罗斯联邦”（图1-2）<!-- raw HTML omitted -->🔻内塔尼亚胡被国际刑事法院指控为（图3-4）：<!-- raw HTML omitted -->🔹- 将平民挨饿作为一种战争方法；<!-- raw HTML omitted -->🔹- 故意造成巨大痛苦，或严重伤害身体或健康，或犯有战争罪的残酷待遇；<!-- raw HTML omitted -->🔹- 故意杀 人，或作为战争罪的谋 杀；<!-- raw HTML omitted -->🔹- 故意攻击平民，犯有战争罪；<!-- raw HTML omitted -->🔹- 灭 绝和/或谋 杀，包括因饥饿而死 亡，构成危害人类罪；<!-- raw HTML omitted -->🔹- 作为危害人类罪的迫害；<!-- raw HTML omitted -->🔹- 其他构成危害人类罪的不人道行为。<!-- raw HTML omitted -->🔻via ICC 网站<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OfdavAwgt">中国载人航天工程办公室：不同意。 查看图片 //@齿轮-传动:我说一下我的意见:月球车没什么实用价值，空浪费火箭推力 - 转发 @包容万物恒河水:&amp;ensp;🔻为什么我...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ofdavawgt/">
    
    
    
    
    
      
    
    中国载人航天工程办公室：不同意。 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->查看图片<!-- raw HTML omitted --><!-- raw HTML omitted --> //<!-- raw HTML omitted -->@齿轮-传动<!-- raw HTML omitted -->:我说一下我的意见:月球车没什么实用价值，空浪费火箭推力<!-- raw HTML omitted -->&lt;blockquo &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Ofdg3EjzH">阿波罗11号的阿姆斯特朗和奥尔德林，步行的范围比足球场还小。阿波罗17号的塞尔南和施密特，开车35.9公里，这就是意义。 查看图片 //@齿轮-传动:你没看视频里他...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ofdg3ejzh/">
    
    
    
    
    
      
    
    阿波罗11号的阿姆斯特朗和奥尔德林，步行的范围比足球场还小。阿波罗17号的塞尔南和施密特，开车35.9公里，这就是意义。 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->查看图片<!-- raw HTML omitted --><!-- raw HTML omitted --> //&lt;a href=&ldquo;<a href="https://weibo.com/n/%E9%BD%BF%E8%BD%AE-%E4%BC%A0%E5%8A%A8">https://weibo.com/n/%E9%BD%BF%E8%BD%AE-%E4%BC%A0%E5%8A%A8</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OfdgAxSf8">我就说京子心软，你们还不信。 - 转发 @包容万物恒河水:&amp;ensp;🔻将国际刑事法院对普京和内塔尼亚胡的逮捕令申请进行比较很有意思。🔻普京被国际刑事法院指控...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ofdgaxsf8/">
    
    
    
    
    
      
    
    我就说京子心软，你们还不信。<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@包容万物恒河水<!-- raw HTML omitted -->: 🔻将国际刑事法院对普京和内塔尼亚胡的逮捕令申请进行比较很有意思。<!-- raw HTML omitted -->🔻普京被国际刑事法院指控为“非法驱逐人口（儿童）和非法将人口（儿童）从乌克兰占领地区转移到俄罗斯联邦”（图1-2）<!-- raw HTML omitted -->🔻内塔尼亚胡被国际刑事法院指控为（图3-4）：<!-- raw HTML omitted -->🔹- 将平民挨饿作为一种战争方法；<!-- raw HTML omitted -->🔹- 故意造成巨大痛苦，或严重伤害身体或健康，或犯有战争罪的残酷待遇；<!-- raw HTML omitted -->🔹- 故意杀 人，或作为战争罪的谋 杀；<!-- raw HTML omitted -->🔹- 故意攻击平民，犯有战争罪；<!-- raw HTML omitted -->🔹- 灭 绝和/或谋 杀，包括因饥饿而死 亡，构成危害人类罪；<!-- raw HTML omitted -->🔹- 作为危害人类罪的迫害；<!-- raw HTML omitted -->🔹- 其他构成危害人类罪的不人道行为。<!-- raw HTML omitted -->🔻via ICC 网站&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax3.sinaimg.cn/larg">https://tvax3.sinaimg.cn/larg</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OfdjfC015">🔻来中国旅游的外国博主正在全方位承担起“自发外宣”的工作。🔻比如这个视频，作者是 Eoin and Aisling🔻这些外国旅游博主甚至卷起来了，制作视频水平越...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ofdjfc015/">
    
    
    
    
    
      
    
    🔻来中国旅游的外国博主正在全方位承担起“自发外宣”的工作。<!-- raw HTML omitted -->🔻比如这个视频，作者是 Eoin and Aisling<!-- raw HTML omitted -->🔻这些外国旅游博主甚至卷起来了，制作视频水平越来越高，去的城市越来越多，他们正在尽量尝试拍摄别的博主没有拍摄过的内容、到达别的博主没有到达过的角落，发现的中国之美也越来越多。<!-- raw HTML omitted -->🔻144小时和许多国家免签真是神来之笔。 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->包容万物恒河水的微博视频<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;div style=&ldquo;clear: &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OfdmmrHcq">？？？？ - 转发 @无心简影:&amp;ensp;#黄家驹墓碑遭男子狂砸# 黄家强昨天发帖子把事件上升到国家后，评论区翻车，大概被骂到不行了，他深夜又在自己评论区狡辩这是...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ofdmmrhcq/">
    
    
    
    
    
      
    
    ？？？？<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@无心简影<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted -->#黄家驹墓碑遭男子狂砸#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted -->黄家强昨天发帖子把事件上升到国家后，评论区翻车，大概被骂到不行了，他深夜又在自己评论区狡辩 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OfdmwwFTv">🔻曼联球迷，百感交集。 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ofdmwwftv/">
    
    
    
    
    
      
    
    🔻曼联球迷，百感交集。 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Ofdn3gkrp">不会，尤其是数学，不会就是不会。//@一个回光返照的理想主义者:小学就不及格会不会有点夸张了 - 转发 @专业戳轮胎熊律师:&amp;ensp;给你们看，真不是编的段子[允悲]...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ofdn3gkrp/">
    
    
    
    
    
      
    
    不会，尤其是数学，不会就是不会。//<!-- raw HTML omitted -->@一个回光返照的理想主义者<!-- raw HTML omitted -->:小学就不及格会不会有点夸张了<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@专业戳轮胎熊律师<!-- raw HTML omitted -->: 给你们看，真不是编的段子<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img alt=&quot;[允悲]&quot; src=&ldquo;<a href="https://h5.sinaimg.cn/m/emoticon/icon/de">https://h5.sinaimg.cn/m/emoticon/icon/de</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/2103074805/Of7fE1d1P">i人要开始装e人了[单身狗] [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-2103074805-of7fe1d1p/">
    
    
    
    
    
      
    
    i人要开始装e人了<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/Of9qg601B">自动精选评论 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-of9qg601b/">
    
    
    
    
    
      
    
    自动精选评论 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/Of9VRkohN">建议新闻这样写：LG杯首轮 日方全败 中韩战平</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-of9vrkohn/">
    
    
    
    
    
      
    
    建议新闻这样写：<!-- raw HTML omitted -->LG杯首轮 日方全败 中韩战平  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/OfagdCysH">不是，卡皇老芈这是造了什么孽？</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-ofagdcysh/">
    
    
    
    
    
      
    
    不是，卡皇老芈这是造了什么孽？  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/OfbnR5Y45">有一说一，匹诺康尼大剧院的BGM给我一种浓郁的怀斯曼既视感，仔细听了几遍感觉像Etude of the Ruin与福音计划的二合一版本。再看看木头老爷的的贴纸，更像了[笑...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-ofbnr5y45/">
    
    
    
    
    
      
    
    有一说一，匹诺康尼大剧院的BGM给我一种浓郁的怀斯曼既视感，仔细听了几遍感觉像Etude of the Ruin与福音计划的二合一版本。再看看木头老爷的的贴纸，更像了<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OfbD3piaM">转发微博 - 转发 @山下美月教会:&amp;ensp;山下美月 Webshop [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-ofbd3piam/">
    
    
    
    
    
      
    
    转发微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@山下美月教会<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->山下美月<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted -->Webshop &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax4.sinaimg.cn/large/005OQbTzgy1hpw6bl0u2kj30sw0sw14r.jpg%22">https://tvax4.sinaimg.cn/large/005OQbTzgy1hpw6bl0u2kj30sw0sw14r.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OfbDIc45l">转发微博 - 转发 @山下美月教会:&amp;ensp;山下美月#山下美月手机博# 240520久违地去购物了live的时候有个孩子穿了RESEXXY来的让我很开心啊 这个是RESEXXY美丽月亮店...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-ofbdic45l/">
    
    
    
    
    
      
    
    转发微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@山下美月教会<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->山下美月<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E5%B1%B1%E4">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E5%B1%B1%E4</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/Ofd0ZsvEE">转发微博 - 转发 @顶筆TEN使:&amp;ensp;久保史绪里#shiorigram# 之后19：00（JST）～有nogiobi～直播～请一定来看看。 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-ofd0zsvee/">
    
    
    
    
    
      
    
    转发微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23shiorigram%23">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23shiorigram%23</a>&amp; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/Ofd1155rj">转发微博 - 转发 @顶筆TEN使:&amp;ensp;久保史绪里via.乃木坂46 X [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-ofd1155rj/">
    
    
    
    
    
      
    
    转发微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->via.乃木坂46 X &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax3.sinaimg.cn/large/006z6nxLgy1hpw5bxsojhj31500usqam.jpg%22">https://tvax3.sinaimg.cn/large/006z6nxLgy1hpw5bxsojhj31500usqam.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/Ofd4VFR29">转发微博 - 转发 @钢波Orz:&amp;ensp;久保史绪里做完纱纱留的作业“用手弄个双马尾”之后因为过于害羞而发出可爱怪叫的久保绪[开学季]一瞬间的双马尾竟然能让她那么...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-ofd4vfr29/">
    
    
    
    
    
      
    
    转发微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@钢波Orz<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->做完纱纱留的作业“用手弄个双马尾”之后<!-- raw HTML omitted -->因为过于害羞而发出可爱怪叫的久保绪<!-- raw HTML omitted -->&lt;img alt=&quot;[开学季]&quot; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OfehNyYuC">想见她，想找她吃饭😭</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-ofehnyyuc/">
    
    
    
    
    
      
    
    想见她，想找她吃饭😭  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/OfbabuSig">緒害羞 [图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-ofbabusig/">
    
    
    
    
    
      
    
    緒害羞 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/Ofa2fagwM">问：井山为什么没有来LG杯答：如图所示#围棋#围棋 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-ofa2fagwm/">
    
    
    
    
    
      
    
    问：井山为什么没有来LG杯<!-- raw HTML omitted --><!-- raw HTML omitted -->答：如图所示<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#围棋#<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->围棋<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;img style=&quot;&quot; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/OfaaX2aBk">LG杯第二轮对阵申旻埈-赖均辅朴廷桓-芝野虎丸卞相壹-芈昱廷申真谞-韩相朝李昌锡-柯洁元晟溱-许家元金真辉-丁浩李志贤-许皓鋐#围棋#围棋</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-ofaax2abk/">
    
    
    
    
    
      
    
    LG杯第二轮对阵<!-- raw HTML omitted --><!-- raw HTML omitted -->申旻埈-赖均辅<!-- raw HTML omitted -->朴廷桓-芝野虎丸<!-- raw HTML omitted -->卞相壹-芈昱廷<!-- raw HTML omitted -->申真谞-韩相朝<!-- raw HTML omitted -->李昌锡-柯洁<!-- raw HTML omitted -->元晟溱-许家元<!-- raw HTML omitted -->金真辉-丁浩<!-- raw HTML omitted -->李志贤-许皓鋐<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#围棋#<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://n.sinaimg.cn/photo/5213b46e/20180926/timeline_card_small_super_de">https://n.sinaimg.cn/photo/5213b46e/20180926/timeline_card_small_super_de</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/OfahrstYx">今日LG杯进行了首轮争夺，在六场中韩战中，双方平分秋色，各晋级3名棋手。[鼓掌][鼓掌][鼓掌][鼓掌][鼓掌]此外日本名将伊田笃史不敌韩国棋手出局。[哈哈][哈哈][...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-ofahrstyx/">
    
    
    
    
    
      
    
    今日LG杯进行了首轮争夺，在六场中韩战中，双方平分秋色，各晋级3名棋手。<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img alt=&quot;[鼓掌]&quot; src=&ldquo;<a href="https://h5.sinaimg.cn/m/emoticon/icon/default/d_guzhang-cca8b296d9.png%22">https://h5.sinaimg.cn/m/emoticon/icon/default/d_guzhang-cca8b296d9.png&quot;</a> style=&ldquo;width:1em; height:1em;&rdquo; referrerpolicy=&ldquo;no-referrer &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/OfdKsjlZ5">井山没有参加LG杯的原因：其实是自己辞退了参加LG杯的资格，井山裕太觉得自己“没有达到可以能和顶尖棋手抗衡的水平”，于是把日本棋手的参赛名额让给了其他棋手...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-ofdksjlz5/">
    
    
    
    
    
      
    
    井山没有参加LG杯的原因：<!-- raw HTML omitted --><!-- raw HTML omitted -->其实是自己辞退了参加LG杯的资格，井山裕太觉得自己“没有达到可以能和顶尖棋手抗衡的水平”，于是把日本棋手的参赛名额让给了其他棋手。<!-- raw HTML omitted --><!-- raw HTML omitted -->向来重视世界大赛的井山裕太，之前都是因为赛程原因无法参加比赛，但是由本人提出不参加世界大赛的情况还是第一次。<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#围棋#<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/Ofe0gkpQ4">赵治勋的连载更新慢的理由：赵治勋的连载在日本经济新闻是付费文章，而日本经济新闻的免费会员，【一个月只能看一篇】付费文章。并且一个月的费用比较贵，and我...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-ofe0gkpq4/">
    
    
    
    
    
      
    
    赵治勋的连载更新慢的理由：<!-- raw HTML omitted --><!-- raw HTML omitted -->赵治勋的连载在日本经济新闻是付费文章，而日本经济新闻的免费会员，【一个月只能看一篇】付费文章。并且一个月的费用比较贵，and我不太想在那个平台留下我的信用卡卡号，所以我不想注册付费以及免费使用名额。<!-- raw HTML omitted --><!-- raw HTML omitted -->为了打破这个窘境，唯一的办法是注册新的邮箱，众所周知注册帐号再怎么样也是一件比较麻烦的事情，所以我就随缘注册新ID然后更新文章了。<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img alt=&quot;[二哈]&quot; src=&ldquo;<a href="https://h5.sinaimg.cn/m/emoticon/icon/others/d_erha-139d0e07bd.png">https://h5.sinaimg.cn/m/emoticon/icon/others/d_erha-139d0e07bd.png</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OfaMMcrDb">久保史绪里#shiorigram# 之后19：00（JST）～有nogiobi～直播～请一定来看看。 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-ofammcrdb/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#shiorigram#<!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OfaYjhRAa">久保史绪里via.乃木坂46 X [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-ofayjhraa/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->via.乃木坂46 X <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/7332621109/OfbTjo1Xa">[666] - 转发 @棋士柯洁:&amp;ensp;在520这天，居然收到了一位韩国大叔送的礼物[送花花]很开心，有哪位同学可以讲一下扇子上这是哪两个字？ [图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-7332621109-ofbtjo1xa/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@棋士柯洁<!-- raw HTML omitted -->: 在520这天，居然收到了一位韩国大叔送的礼物<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->很开心，有哪位同学可以讲一下扇子上这是哪两个字？ &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax3.sinaim">https://tvax3.sinaim</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/7332621109/OfbWi0IAD">柯洁#LG杯##赛事预告#22日上午九点LG本赛第二轮比赛柯洁九段VS李昌锡九段。柯柯比赛加油[彩虹屁] [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-7332621109-ofbwi0iad/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->柯洁<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#LG杯#<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/7332621109/OfcNA6EzN">柯洁#LG杯# 昨日图集① [图片][图片][图片][图片][图片][图片][图片][图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-7332621109-ofcna6ezn/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->柯洁<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#LG杯#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted -->昨日图集① &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax1.sinaimg.cn/large/0080eVIply1hpwdf37o89j30k00csn0">https://tvax1.sinaimg.cn/large/0080eVIply1hpwdf37o89j30k00csn0</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/7332621109/OfcON17zL">柯洁#LG杯# 昨日图集② [图片][图片][图片][图片][图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-7332621109-ofcon17zl/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->柯洁<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#LG杯#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted -->昨日图集② &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax4.sinaimg.cn/large/0080eVIply1hpwdic30uzj30iw0cla">https://tvax4.sinaimg.cn/large/0080eVIply1hpwdic30uzj30iw0cla</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/7332621109/OfcPomEBt">柯洁#lg杯# 昨日图集③ [图片][图片][图片][图片][图片][图片][图片][图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-7332621109-ofcpomebt/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->柯洁<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#lg杯#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted -->昨日图集③ &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax1.sinaimg.cn/large/0080eVIply1hpwd">https://tvax1.sinaimg.cn/large/0080eVIply1hpwd</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/7332621109/OfcPRlgjV">柯洁#lg杯# 昨日图集来源:弈客围棋 太极网 乌鹭网 韩游网 twi fb</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-7332621109-ofcprlgjv/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->柯洁<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#lg杯#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted -->昨日图集来源:弈客围棋 太极网 乌鹭网 韩游网 twi fb  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/7332621109/OfcV1CPHx">柯洁#lg杯# 今日图集① [图片][图片][图片][图片][图片][图片][图片][图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-7332621109-ofcv1cphx/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->柯洁<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#lg杯#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted -->今日图集① &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax3.sinaimg.cn/large/0080eVIply1hpwd">https://tvax3.sinaimg.cn/large/0080eVIply1hpwd</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/7332621109/OfcWf6IY1">柯洁#lg杯# 今日图集② [图片][图片][图片][图片][图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-7332621109-ofcwf6iy1/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->柯洁<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#lg杯#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted -->今日图集② &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax4.sinaimg.cn/large/0080eVIply1hpw">https://tvax4.sinaimg.cn/large/0080eVIply1hpw</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/7332621109/OfcXareU3">柯洁#lg杯# 今日图集来源:弈客围棋 太极网 乌鹭网 韩游网 ins</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-7332621109-ofcxareu3/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->柯洁<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#lg杯#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted -->今日图集来源:弈客围棋 太极网 乌鹭网 韩游网 ins  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.zhihu.com/question/23032129/answer/3504523167">猫哥的视界回答了问题: 古代人生活是不是很苦？</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/www-zhihu-com-question-23032129-answer-3504523167/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.zhihu.com/question/378357555/answer/3504516547">猫哥的视界回答了问题: 美军是不是拉了？感觉这几年没什么大动静?</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/www-zhihu-com-question-378357555-answer-3504516547/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.zhihu.com/question/622082097/answer/3504520117">猫哥的视界回答了问题: 万历三大征是否消耗掉了明朝的国力？</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/www-zhihu-com-question-622082097-answer-3504520117/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.zhihu.com/question/656591265/answer/3504548801">张敬信回答了问题: 鸢尾花kmeans算法怎么计算准确率？</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/www-zhihu-com-question-656591265-answer-3504548801/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.zhihu.com/question/656595100/answer/3504564920">张敬信回答了问题: 大佬，请问r语言里这个图怎么画？</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/www-zhihu-com-question-656595100-answer-3504564920/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/698826550">量子位发表了文章: 明星大模型创企被曝换帅：清华教授创始人另有任用</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-698826550/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/698835420">量子位发表了文章: 鹅厂革新大模型工具全链条！5分钟开发AI助手，河南学生已用上</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-698835420/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/698850008">量子位发表了文章: 从零复现Llama3代码库爆火，大神Kapathy一键三连，GitHub狂揽2k&#43;</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-698850008/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/698876034">量子位发表了文章: LoRA数学编程任务不敌全量微调 | 哥大&amp;Databricks新研究</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-698876034/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/698877563">量子位发表了文章: 北大袁粒：用户不会为只能闲聊的大模型买单 | 中国AIGC产业峰会</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-20</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-698877563/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

</main>
</div>

<script async src="//yihui.name/js/center-img.js"></script>

<footer>

<div class="footer">
  <ul class="menu">
    
    <li><a href="/"><span data-hover="Home">Home</span></a></li>
    
    <li><a href="/about/"><span data-hover="About">About</span></a></li>
    
    <li><a href="/archives/"><span data-hover="Archive">Archive</span></a></li>
    
    <li><a href="/contributor/"><span data-hover="Contributor">Contributor</span></a></li>
    
    <li><a href="/index.xml"><span data-hover="Subscribe">Subscribe</span></a></li>
    
  </ul>
  
  <div class="copyright">© <a href="https://rainoffallingstar.github.io">Fallingstar</a> 2023 | <a href="https://github.com/rainoffallingstar">Github</a></div>
  
</div>
</footer>







</body>
</html>

